Agilent, 683975-913, AdvanceBio Glycan Mapping 120Å, 4.6 x 150 mm, 2.7 µm

AdvanceBio Glycan Mapping 120Å, 4.6 x 150 mm, 2.7 µm. This column has superficially porous particles with amide HILIC chemistry for high resolution at <600 bar pressure.

Specifications:
Brand: AdvanceBio Glycan Mapping
Hardware: SS
Inner Diameter (ID): 4.6 mm
LC Platform: Stainless Steel
Length: 150 mm
Maximum Temperature: 40 °C
Part Number Application: Glycan Analysis
Part Number Application Domain: Biopharma
Particle Size: 2.7 µm
Particle Type: Superficially Porous
Phase: Amide HILIC
Pore Size: 120 Å
Pressure Rating: 600 bar
Separation Mode: HILIC
Shipping Solvent: Acetonitrile/Water
Technique: LC & LC/MS
UNSPSC Code: 41115711
pH Range: 2-7

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
The AdvanceBio Glycan Mapping 4.6 x 150 mm, 2.7 µm, 120 angstrom column is expertly engineered for high-resolution, reproducible glycan analysis by liquid chromatography. Utilizing advanced superficially porous particle technology, this column delivers exceptional separation of complex glycan mixtures, enabling detailed glycan profiling and structural elucidation in biopharmaceutical research and quality control environments.

Its optimized 120 angstrom pore size and 2.7 micron particle size facilitate rapid separation of released N-linked and O-linked glycans derived from monoclonal antibodies, therapeutic proteins, and other biologics. The column is ideal for HILIC-based workflows, supporting both routine and advanced glycan mapping applications that require excellent sensitivity and robust quantitation.

This column is fully compatible with Agilent’s InfinityLab LC systems and seamlessly integrates with a range of UHPLC and HPLC platforms. It performs optimally with fluorescence and mass spectrometry detection, supporting a broad array of analytical protocols. Pairing with AdvanceBio sample preparation kits and glycan standards maximizes reproducibility and data confidence.

Designed for researchers focusing on glycosylation profiling, lot-to-lot comparability, biosimilarity assessment, and regulatory compliance, this column ensures accurate, efficient, and reliable glycan characterization for biopharmaceutical development and manufacturing pipelines.